Fanconi syndrome historical perspective

Jump to navigation Jump to search

Fanconi syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fanconi syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study Of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fanconi syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fanconi syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fanconi syndrome historical perspective

CDC on Fanconi syndrome historical perspective

Fanconi syndrome historical perspective in the news

Blogs on Fanconi syndrome historical perspective

Directions to Hospitals Treating Fanconi syndrome

Risk calculators and risk factors for Fanconi syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Fanconi syndrome is nominated after the name of professor Guido Fanconi, who first explained the characteristics of the disease in 1931. He investigated and proposed the possible links between dwarfing and hypophosphataemic rickets to renal glycosuria in children suffering from the disease. 

Historical Perspective

Discovery

  • Simultaneous rickets and albuminuria due to kidney disease was first described in 1881 referred as ‘disorder of adolescence', but the precise mechanism remained unknown[1].
  • Fanconi syndrome was first explained as a renal proximal tubule defect with details by Guido Fanconi, a swiss pediatrician ,in 1931[2].
  • Besides Dr. Fanconi, the clinical charactristics of the disease were further studied by Debre and De toni, that’s why the disease is also called Debre-De Toni-Fanconi syndrome[3][4].
  • in 1949 Professor Fanconi and his assistant Dr. Horst Bickel, described a rare type of Glycogen storage disease characterized by GLUT2 glucose transporter mutations which leads to liver, pancreas and kidney failure. The disease was further named Fanconi-Bickel syndrome, Although the renal involvment of this syndrome is mostly the renal Fanconi syndrome, but these two syndromes are separate diseases[5].
  • Later on, the syndrome clinical characteristics were studied by many other scientists. As the Fanconi syndrome can result from many genetic disorders with various etiologies, effect of drugs and substances on the kidney, and also is one of the characteristics included in many complicated syndromes, the details of pathophysiology and genetic perspective of the disease is becoming more evident gradually from 40s decade. 
  • Even now in 2017 there are novel mutations and genetic loci discovered leading to the disease[6].

Landmark Events in the Development of Treatment Strategies

    • in 1950s, General treatment aspects of the disease(replacement therapy) was first proposed and is still remains as the main therapeutic approach[7].
    • Specific therapies modifying the underlying diseases continued to be introduced with the progression of disease comprehension. 

References

Template:WH Template:WS